| UNITED THERAPEUTICS |
| USA |
| Gesundheit |
| US91307C1027 / 923818 |
| UTH (Frankfurt) / UTHR (NASDAQ) |
| FRA:UTH, ETR:UTH, UTH:GR, NASDAQ:UTHR |
| - |
| http://www.unither.com/ |
|
United Therapeutics Corporation is a biotechnology company specializing in therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease, and ot..
>Volltext.. |
| 19976.48 Mio. EUR |
| 17484.88 Mio. EUR |
| 2741.39 Mio. EUR |
| 1379.35 Mio. EUR |
| 1149.63 Mio. EUR |
| 26 EUR |
| - |
| 1341.19 Mio. EUR |
| 1344.73 Mio. EUR |
| 5.21 |
| -2.51% |
| -1.56% |
| - |
| - |
| - |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 67.410.439 USD. |
| UNITED THERAPEUTICS, UNITED THERAPEUTIC, UNITED THERA |
| 11.03.26 |